Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albiglutide vs Liraglutide in Type 2 Diabetes (HARMONY 7)
NCT01128894Phase 3Completed
- Sponsor
- GSK
- Start
- May 2010
- Primary completion
- Sep 2011
- Modality
- Fc-Fusion Proteins
- Countries
- 8
01
Overview
Phase 3, randomised, open-label trial of albiglutide in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by GSK. Primary endpoint: Glycosylated Hemoglobin at 32 weeks. Started May 2010; status: completed.
02
Drugs
albiglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01128894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01128894.